| Eva Linden, NP | |
|
1823 Vt Rte 107, Bethel, VT 05032-9107 | |
| (802) 234-9913 | |
| Not Available |
| Full Name | Eva Linden |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 1823 Vt Rte 107, Bethel, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720429145 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gifford Health Care Inc | 2668624982 | 33 |
News Archive
Details of a new method to detect diabetic neuropathy in patients in less than five minutes using their sweat glands was presented today at the American Association of Clinical Endocrinologists 22nd Annual Scientific and Clinical Congress in Phoenix, Arizona by Aaron I. Vinik, M.D., Ph.D., F.C.P., M.A.C.P., F.A.C.E., Professor of Medicine and Director of Research and the Neuroendocrine Unit at Eastern Virginia Medical School.
Inflammatory myofibroblastic tumor (IMT) is an uncommon benign neoplasm with locally aggressive behavior but malignant change is rare. Such a rare tumor occurring in a 14-year-old patient with clinical presentations of abdominal pain and body weight loss was seldom described before.
Cappella, Inc. (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, promoted their serial IVUS analysis & Sideguard® 3.25 device during the Joint Interventional Meeting (JIM) in Rome. Gary S. Mintz, MD, Cardiovascular Research Foundation, New York, USA presented "Positive Vessel Remodeling Using Sideguard in Coronary Bifurcations" during the New Technologies 1 Symposium.
The Stride Rite Children's Group, the leading provider of premier children's footwear, recently announced the launch of a new collection of baby shoes with patent-pending Sensory Response Technology™ (SRT™). Representatives from Stride Rite will be at the American Academy of Pediatrics (AAP) National Conference & Exhibition in Washington, D.C. Oct. 17-20, to discuss the many benefits of the SRT Collection.
› Verified 1 days ago
| Entity Name | Gifford Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942329446 PECOS PAC ID: 4880683663 Enrollment ID: O20040507000460 |
News Archive
Details of a new method to detect diabetic neuropathy in patients in less than five minutes using their sweat glands was presented today at the American Association of Clinical Endocrinologists 22nd Annual Scientific and Clinical Congress in Phoenix, Arizona by Aaron I. Vinik, M.D., Ph.D., F.C.P., M.A.C.P., F.A.C.E., Professor of Medicine and Director of Research and the Neuroendocrine Unit at Eastern Virginia Medical School.
Inflammatory myofibroblastic tumor (IMT) is an uncommon benign neoplasm with locally aggressive behavior but malignant change is rare. Such a rare tumor occurring in a 14-year-old patient with clinical presentations of abdominal pain and body weight loss was seldom described before.
Cappella, Inc. (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, promoted their serial IVUS analysis & Sideguard® 3.25 device during the Joint Interventional Meeting (JIM) in Rome. Gary S. Mintz, MD, Cardiovascular Research Foundation, New York, USA presented "Positive Vessel Remodeling Using Sideguard in Coronary Bifurcations" during the New Technologies 1 Symposium.
The Stride Rite Children's Group, the leading provider of premier children's footwear, recently announced the launch of a new collection of baby shoes with patent-pending Sensory Response Technology™ (SRT™). Representatives from Stride Rite will be at the American Academy of Pediatrics (AAP) National Conference & Exhibition in Washington, D.C. Oct. 17-20, to discuss the many benefits of the SRT Collection.
› Verified 1 days ago
| Entity Name | Gifford Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013269430 PECOS PAC ID: 2668624982 Enrollment ID: O20121213000467 |
News Archive
Details of a new method to detect diabetic neuropathy in patients in less than five minutes using their sweat glands was presented today at the American Association of Clinical Endocrinologists 22nd Annual Scientific and Clinical Congress in Phoenix, Arizona by Aaron I. Vinik, M.D., Ph.D., F.C.P., M.A.C.P., F.A.C.E., Professor of Medicine and Director of Research and the Neuroendocrine Unit at Eastern Virginia Medical School.
Inflammatory myofibroblastic tumor (IMT) is an uncommon benign neoplasm with locally aggressive behavior but malignant change is rare. Such a rare tumor occurring in a 14-year-old patient with clinical presentations of abdominal pain and body weight loss was seldom described before.
Cappella, Inc. (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, promoted their serial IVUS analysis & Sideguard® 3.25 device during the Joint Interventional Meeting (JIM) in Rome. Gary S. Mintz, MD, Cardiovascular Research Foundation, New York, USA presented "Positive Vessel Remodeling Using Sideguard in Coronary Bifurcations" during the New Technologies 1 Symposium.
The Stride Rite Children's Group, the leading provider of premier children's footwear, recently announced the launch of a new collection of baby shoes with patent-pending Sensory Response Technology™ (SRT™). Representatives from Stride Rite will be at the American Academy of Pediatrics (AAP) National Conference & Exhibition in Washington, D.C. Oct. 17-20, to discuss the many benefits of the SRT Collection.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eva Linden, NP 1823 Vt Rte 107, Bethel, VT 05032-9107 Ph: () - | Eva Linden, NP 1823 Vt Rte 107, Bethel, VT 05032-9107 Ph: (802) 234-9913 |
News Archive
Details of a new method to detect diabetic neuropathy in patients in less than five minutes using their sweat glands was presented today at the American Association of Clinical Endocrinologists 22nd Annual Scientific and Clinical Congress in Phoenix, Arizona by Aaron I. Vinik, M.D., Ph.D., F.C.P., M.A.C.P., F.A.C.E., Professor of Medicine and Director of Research and the Neuroendocrine Unit at Eastern Virginia Medical School.
Inflammatory myofibroblastic tumor (IMT) is an uncommon benign neoplasm with locally aggressive behavior but malignant change is rare. Such a rare tumor occurring in a 14-year-old patient with clinical presentations of abdominal pain and body weight loss was seldom described before.
Cappella, Inc. (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, promoted their serial IVUS analysis & Sideguard® 3.25 device during the Joint Interventional Meeting (JIM) in Rome. Gary S. Mintz, MD, Cardiovascular Research Foundation, New York, USA presented "Positive Vessel Remodeling Using Sideguard in Coronary Bifurcations" during the New Technologies 1 Symposium.
The Stride Rite Children's Group, the leading provider of premier children's footwear, recently announced the launch of a new collection of baby shoes with patent-pending Sensory Response Technology™ (SRT™). Representatives from Stride Rite will be at the American Academy of Pediatrics (AAP) National Conference & Exhibition in Washington, D.C. Oct. 17-20, to discuss the many benefits of the SRT Collection.
› Verified 1 days ago
Ms. Susan Lea Thievon, M.S., APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1823 Vt Rte 107, Bethel, VT 05032 Phone: 802-234-9913 |